Poor Performance Status
9
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
14 treatments under study, led by Srwbv
Research Leaders
11 sponsors active, led by Bern University of Applied Sciences
Related Conditions
Often studied with 13 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
11%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (9)
Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status
SR-WBV Training for Frail Elderly in the Skilling up Stage
Innovative Training Program for Elderly in Need of Care
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
Nighttime Feeding and Morning Endurance Performance
Innovative Training Program for Elderly in Need of Care Individuals
Innovative Training Methods for Frail Elderly in the Training Gain Stage
Saving Brain in Uganda and Burkina Faso
Minocycline Treatment in Acute Hemorrhagic Stroke
Research Network
Common Treatments
- Srwbv3
- Exergame2
- Irinotecan Hydrochloride1
- Chocolate Milk1
- Virtual Games Vg1
Active Sponsors
- Bern University of Applied Sciences4
- Swiss Federal Institute of Technology3
- Goethe University2
- Maastricht University Medical Center2
- Guangzhou Institute of Respiratory Disease1
Top Investigators
Bern University of Applied Sciences
Bern University of Applied Science, Department WGS
Johann Wolfgang Goethe University, Department Sport Science
University of California, Davis
ETHZ
Related Conditions
- Muscle Weakness2
- Cognition Other1
- Malignant Tumor Of Lung1
- Mixed Behavior And Emotional Disorder1
- Malnutrition1